Work

Mitochondria as a therapeutic target in Alzheimer's disease

Year: 2016
Type: review
Abstract: Alzheimer's disease (AD) remains the most common neurodegenerative disease characterized by β-amyloid protein (Aβ) deposition and memory loss. Studies have shown that mitochondrial dysfunction plays a crucial role in AD, which involves oxidative stress-induced respiratory chain dysfunction, loss of mitochondrial biogenesis, defects of mitochondrial dynamics and mtDNA mutations. Thus mitochondria might serve as drug therapy target for AD. In this article, we first briefly discussed mitochondrial theory in the development of AD, and then we summarized recent advances of mitochondrial abnormalities in AD pathology and introduced a series of drugs and techniques targeting mitochondria. We think that maintaining mitochondrial function may provide a new way of thinking in the treatment of AD.
Authors: Jian Wang, Guo-Jun Chen
Language: English
Open Access status: gold
Estimated APC paid: $2,500
OpenAlex ID: W2155512990
FWCI: 0.234
Cites: 94
Cited by: 48
Related to: 10